On the Benign Side of Malignancy: How Neuroendocrine Tumors are Experienced by Patients and Their Family Carers Abstract #829

Introduction: Neuroendocrine tumors (NETs) are rare, slow-growing neoplasia with variable clinical presentations. Due to their non-specific symptoms and a lack of diagnostic tools, late diagnosis is common. There is little research relating to NETs as experienced by both patients and family carers.
Aim(s): This qualitative study examined experiences of patients with NETs and their family carers and how they managed to cope with the disease on a daily basis.
Materials and methods: Eight patients and eight family members from an oncology outpatient clinic and a support group were interviewed. Content analysis methodology was adopted for data analysis.
Conference: 11th Annual ENETS Conference (2014)
Category: ...none of the below
Presenting Author: Susanne Kall

To read results and conclusion, please login ...

Further abstracts you may be interested in

#731 Gastroenteropancreatic (GEP) Neuroendocrine Tumors, Epidemiology and Clinical Retrospective Study from a Tertiary Care Center in North India
Introduction: Neuroendocrine tumors (NETs) are a heterogeneous group of neoplasm derived from peptide- and amine-producing cells of the neuroendocrine system, characterized by the intracellular presence of markers of endocrine tissue, like chromogranin A, synaptophysin, neuronspecific enolase and having low to medium malignant potential.
Conference: 10th Annual ENETS Conference (2013)
Category: Epidemiology/Natural history/Prognosis - Registries, nationwide and regional surveys
Presenting Author: Dr Dipanjan Panda
#867 Mixed Adenoneuroendocrine Carcinoma (MANECs): A Rare and Challenging Subgroup of Neuroendocrine Neoplasia
Introduction: Mixed Adenoneuroendocrine Carcinomas (MANECs) are rare entities in which at least 30% of neoplastic cells are neuroendocrine in nature (WHO 2010 classification). They result either from two independent lesions that merge together or are unique lesions with different cell populations intermingled.
Conference: 11th Annual ENETS Conference (2014)
Category: Pathology, grading, staging
Presenting Author: Dr Conor Mosli Lynch
#2177 Assessment of Quality of Life in Chinese Patients with Gastroenteropancreatic Neuroendocrine Tumors
Introduction: Descriptive analysis on the QOL in patients(pts) with GEP-NET are rare.
Conference: 15th Annual ENETS conference (2018)
Category: Epidemiology/Natural history/Prognosis- Registries, nationwide and regional surveys
Presenting Author: Prof. Huang-Ying Tan
Authors: Liu Q, Li Y L, Qiu X D, Li X K, ...
#162 Different sites of rare metastases in neuroendocrine tumor patients detected by Ga-68 somatostatin receptor PET/CT
Introduction: The most common sites of metastases in neuroendocrine tumors are liver, lymph nodes, and bone.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr. Vikas Prasad
Authors: Prasad V, Baum R P, ...
#1182 Epirubicin Loaded Polyphosphazene; A New Agent Against Small Intestinal Neuroendocrine Tumors and Medullary Thyroid Carcinomas
Introduction: Small intestinal neuroendocrine tumors (SI-NETs) represent a group of rare neoplasms, derived mainly from enterochromaffine cells. Medullary thyroid carcinoma (MTC) is a calcitonin-producing neuroendocrine tumor arising from the parafollicular C-cells. SI-NETs as well as MTCs are known for their poor response to standard therapy. Therefore, there is a substantial need to establish new therapeutic options in the clinical treatment of these tumors.
Conference: 12th Annual ENETS Conference (2015)
Category: ...none of the below
Presenting Author: Dr. Gert Schwach
Close
Notice

WARNING – FRAUDULENT WEBSITES

ENETS is aware that its members have been confronted with fake websites, which seem to relate to our congress but have not been commissioned or authorised by us. The websites offer fraudulent hotel reservation services. We therefore strongly recommend that you please only use the official enetsconference.org website when booking your tickets and accommodation. Please be vigilant when it comes to providing your credit card details. 

If you have any questions, please do not hesitate to contact us at info@enets.org.